CORAL GABLES, FL / ACCESSWIRE / June 1, 2015 / Monday morning saw US stock futures climb suggesting a positive open for Wall Street on the first day of the month. Healthcare and biotechnology stocks have helped to spur new bullish sentiment heading into the summer months and even though the markets closed weaker during the final days of May, June may be seeing a rebound. More volatile stocks like those in biotech have taken on a bigger focus in the markets in 2015 and it's not just he bigger stocks seeing this either. Penny stocks, which are inherently volatile, have also seen activity bolstered even during these early summer months. The likes of Oncothyreon, Inc. (ONTY), Coastal Integrated Services, Inc. (COLV), and Accurexa, Inc. (ACXA) have all seen relative increases in market activity during the more recent weeks of trading.

This morning Oncothyreon announced that it had presented positive data from its trials of ONT-380, an orally active, reversible and selective small-molecule HER2 inhibitor for the treatment of breast cancer, at the American Society of Clinical Oncology 2015 Annual Meeting. "Oncothyreon is currently planning a blinded, randomized placebo-controlled Phase 2 trial of ONT-380 in combination with Herceptin and Xeloda for the treatment of HER2-positive metastatic breast cancer in patients who have failed both Perjeta(R) (pertuzumab) and Kadcyla, which we expect to initiate late this year," said Diana Hausman, M.D., Chief Medical Officer of Oncothyreon. "The trial design includes endpoints focused on the prevention and treatment of CNS metastases. We have also now enrolled over 40 patients in our trial of ONT-380 in combination with Kadcyla and continue to evaluate this combination for the treatment of patients with CNS metastases."

Over the last 3 and a half weeks, shares of Oncothyreon have seen an increase in price from initial levels around $1.40 to highs on Monday morning of $4.69. It would appear that these positive trial results have been a boon to shareprice appreciation heading into the month of June.

Another active penny stock opening the new month has been Coastal Integrated Services, Inc. Over recent weeks, the stock has seen a slight increase in price on relatively light volume in comparison to Monday's morning session. Though the price has jumped from lows of $0.0805 to highs on Monday of $0.141, the morning session has shown a drastic increase in selling pressure with volume trending well above the 30-day average. It has been nearly 2 months since the company's last announcement yet pre market activity saw a jump of nearly 40% prior to the opening bell.

Accurexa, Inc. has begun to see trading activity during recent weeks. Following a relatively slow first half of May, volume numbers have increased for this biotech stock, topping out Friday at just under 40,000 shares with a high price of $0.70. The company was recently featured on an episode of "New To The Street," a financial broadcast, which airs in New York, LA, Philadelphia, Boston and Miami. George Yu, CEO, Accurexa, Inc. spoke about the Company's technology for brain cancer and stem cell therapy using its BranchPoint Device. According to the Company, its BranchPoint device was developed at the University of California, San Francisco with $1.8 million in funding from the California Institute for Regenerative Medicine and is based on a neurosurgical delivery platform, which was exclusively licensed from UCSF. Currently the company is developing two programs in its pipeline: The BranchPoint device, which is designed to deliver stem cells or gene therapy as well as its ACX-31, which works to deliver temozolomide, a chemotherapy drug, directly to brain cancer sites with it BranchPoint device.

ABOUT US:

www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase "StockAlerts" to 63566.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.

EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.

EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

CONTACT:

Company: EGM FIRM INC.
Contact Email: adam@egmfirm.com

SOURCE: DailyStockReporter.com